Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Envigo has announced that its Research Models and Services facility in Hyderabad, India has been granted full accreditation by the AAALAC International Council.
read more
Hovione today announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by the US Food and Drug Administration (FDA).
read more
Thursday, December 18, 2014
Hovione today announced that the U.S. Food and Drug Administration (FDA) performed a Pre-Approval Inspection to its plant in Loures, Portugal, covering two NDA filings. At the conclusion of the inspection, the FDA issued a Form 483 with three ...
read more
Wednesday, February 11, 2015
Dishman Group has announced the successful completion of an inspection by the U.S. Food and Drug Administration (FDA) for its Netherlands site. The inspection, carried out by an USFDA investigator, was planned for 5 days but lasted 3 days, starting ...
read more
Wednesday, September 26, 2012
Almac is pleased to announce the successful inspection of its Clinical Services operations located in Craigavon by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
read more
Wednesday, March 13, 2019
SGS welcomed the preliminary data from a controlled human infection trial with FluGen’s investigational M2SR vaccine.
read more
Thursday, September 10, 2026
Summit Clinical Research Solutions has acquired Dallas Research Institute through its Pinnacle Clinical Research site network, expanding its clinical-trial operations in the Dallas-Fort Worth market.
read more
Summit Clinical Research has successfully completed a strategic investment in Houston Research Institute and strengthened its executive team with the appointment of Dr. Mazen Noureddin as Co-Chairman of Summit's Board of Directors and the additions ...
read more
Summit Clinical Research Solutions announced it has unified Summit Clinical Research (SCR) and Pinnacle Clinical Research (PCR) under a single master brand, creating an integrated clinical research organization intended to streamline sponsor ...
read more
Sun Pharmaceutical announced the U.S. launch of Ezallor Sprinkle™ capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing.
read more
Sun announced INFUGEM™, for intravenous use, is now commercially available in the U.S.
read more
Wednesday, February 26, 2020
Sun Pharmaceutical has launched Riomet ER™ in the U.S. to improve glycemic control in patients 10 years of age and older with type 2 diabetes mellitus.
read more
Wednesday, December 26, 2018
DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera from using DUSA's confidential and proprietary trade secret information.
read more
Wednesday, November 28, 2018
Sun Pharmaceutical has entered into a definitive agreement to acquire Pola Pharma, a Japanese pharmaceutical company engaged in research and development, manufacture, sale and distribution of branded and generic products in Japan.
read more
Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab.
read more